Stoke and Biogen publish data showing Dravet syndrome severity
Go back to Stoke and Biogen publish data showing Dravet syndrome severity| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 199.69 +2.50 (1.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $197.19 | 52 Week High | $333.65 | |||
| Open | $199.34 | 52 Week Low | $223.02 | |||
| Day High | $202.06 | P/E | 25.57 | |||
| Day Low | $198.66 | EPS | $7.81 | |||
| Volume | 862,642 | |||||
| (NASDAQ: STOK) | Delayed: 30.38 -0.73 (2.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.11 | 52 Week High | $ | |||
| Open | $31.18 | 52 Week Low | $ | |||
| Day High | $31.96 | P/E | N/A | |||
| Day Low | $30.33 | EPS | $ | |||
| Volume | 518,341 | |||||
